Adipose tissue-derived exosomes contribute to obesity-associated liver diseases in long-term high-fat diet-fed mice, but not in short-term
Introduction
Our study aimed to investigate the changes in hepatic endoplasmic reticulum (ER) stress, inflammation, insulin signaling, and lipid metabolism during the administration of a high-fat diet (HFD) in mice in order to identify correlations between obesity and metabolic disease development in the liver.
Methods
We used short-, medium-, and long-term HFD periods, corresponding to 4, 8, and 12 weeks, respectively, and isolated exosomes from adipose tissue. We confirmed the effect of adipose tissue-derived exosomes on metabolic disorders in obesity in alpha mouse liver 12 (AML12) hepatocytes.
Results
Adipose tissue-derived exosomes from HFD mice did not affect the AML12 cells after 4 weeks, but ER stress, inflammatory response, insulin resistance, and lipid synthesis were observed after 8 and 12 weeks. Furthermore, we confirmed that an HFD increases the amount of adipose tissue-derived exosomes in mice. Consequently, we can infer that adipose tissue-derived exosomes from HFD-fed mice significantly increase ER stress, inflammatory response, insulin resistance, and lipid synthesis in AML12 cells.
Discussion
Our results demonstrate that obesity alters the effects of adipose tissue-derived exosomes in the liver, potentially becoming a risk factor in the development of obesity-induced liver diseases.
Top-30
Journals
|
1
|
|
|
Nature Communications
1 publication, 7.14%
|
|
|
Biology
1 publication, 7.14%
|
|
|
Gene
1 publication, 7.14%
|
|
|
Life Sciences
1 publication, 7.14%
|
|
|
Frontiers in Endocrinology
1 publication, 7.14%
|
|
|
American Journal of Pathology
1 publication, 7.14%
|
|
|
Current Opinion in Endocrine and Metabolic Research
1 publication, 7.14%
|
|
|
Journal of Nanobiotechnology
1 publication, 7.14%
|
|
|
Life
1 publication, 7.14%
|
|
|
Scientific Reports
1 publication, 7.14%
|
|
|
Journal of Proteomics
1 publication, 7.14%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 7.14%
|
|
|
FASEB BioAdvances
1 publication, 7.14%
|
|
|
Frontiers in Pharmacology
1 publication, 7.14%
|
|
|
1
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 42.86%
|
|
|
Springer Nature
3 publications, 21.43%
|
|
|
MDPI
2 publications, 14.29%
|
|
|
Frontiers Media S.A.
2 publications, 14.29%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 7.14%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.